Medigus Announces Study Validating MUSE's Safety and Efficacy in GERD Patients To Be Presented at SAGES 2014

OMER, Israel, March 19, 2014 /PRNewswire/ -- Medigus Ltd. (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and procedures announced today that two oral presentations will highlight the MUSE™ System at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) annual meeting, taking place April 2 - 5, 2014 at the Salt Palace Convention Center, Salt Lake City, Utah.  Medigus is exhibiting at booth # 1113.

"We are honored that the leadership of SAGES has selected two abstracts using our flagship endostapler for presentation at this year's conference," said Chris Rowland, CEO, Medigus. "We believe that these data as well as the growing body of clinical data about MUSE™, underscore its potential as a less-invasive treatment option for patients with severe or chronic GERD as well as future applications such as achalasia." 

Key MUSE™ Oral Presentations at SAGES
Emerging Technology Session
Friday, April 4, 2014 from 3:30-5:50pm, located in Ballroom A-D

• Oral Presentation: ET001 ENDOSCOPIC ANTERIOR FUNDOPLICATION WITH THE MEDIGUS SRS™ TRANSORAL SURGICAL STAPLER: A NOVEL TREATMENT FOR GASTROESOPHAGEAL REFLUX DISEASE Johannes Zachaerl, Bonavina Luigi, Amol Babaye, Ralf Kiesslich, Sebastian Schoppmann, William Kessler, Don Selzer, Michael S Epstein, MD, Glen Lehman, Santiago Horgan, MD
• Oral Presentation: ET006 TRANSORAL TREATMENT OF ACHALASIA: COMBINING SUBMUCOSAL MYOTOMY WITH TRANSORAL FUNDOPLICATION Rosamaira Bozzi, MD, Aviel Roy-Shapira, MD, Fabio Cattaneo, PhD

About SAGES
The mission of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) is to improve quality patient care through education, research, innovation and leadership, principally in gastrointestinal and endoscopic surgery. SAGES is a leading surgical society, representing a worldwide community of over 6,000 surgeons that can bring minimal access surgery, endoscopy and emerging techniques to patients worldwide. The organization sets the clinical and educational guidelines on standards of practice in various procedures, critical to enhancing patient safety and health. The SAGES 2014 Annual Meeting, "Putting the Patient First: Promoting Innovation and Safety in the OR and Beyond," will continue a long-standing tradition of strong didactic sessions by experts, combined with exploration of innovative technology and medical breakthroughs in the fields of general, upper GI, colorectal, endoscopic, robotic and minimally invasive surgery (MIS). This year's meeting will be held at the Salt Palace Convention Center, April 2nd though April 5th. For more information about the annual meeting visit www.sages2014.org or www.sages.org.

About MUSE™
MUSE™ is an intuitive endoscopic platform that consists of a single use surgical endostapler, equipped with a proprietary miniature camera, an ultrasonic sight and a range finder.  The single operator system, performs a surgical anterior fundoplication with standard surgical staples in a less invasive way, compared to other surgical procedures.

About Medigus
Medigus is leading the transition from invasive gastric surgery procedures to less invasive, patient-friendly techniques through the development of minimally invasive endoscopic devices and procedures. The company's revolutionary MUSE™ system enables endoscopists to treat gastroesophageal reflux disease (GERD), a chronic disease with increasing global prevalence, by performing a fundoplication procedure through the mouth.  Unlike current fundoplication procedures, the MUSE™ system does not require abdominal incisions, which may result in shorter post-procedure recovery.  The MUSE™ system (previously known as SRS™ system for transoral fundoplication) has received FDA clearance and CE mark. Medigus is traded on the TASE (Tel Aviv Stock Exchange). To learn more about the company's minimally invasive technology platform, please visit http://www.medigus.com/.

INVESTOR RELATIONS CONTACT:
Miri Segal-Scharia
Hayden/MS-IR LLC
917-607-8654
[email protected]

MEDIA CONTACT:
Chantal Beaudry/Martyna Gawrych
Lazar Partners Ltd.
212-867-1762
[email protected] 
[email protected]

Photo - http://photos.prnewswire.com/prnh/20140212/NY63586

SOURCE Medigus Ltd.